Texas Subject | MEDICINE & PRESCRIPTION DRUGS | Senate

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
TXSB629PassRelating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
[Detail][Text][Discuss]
2023-06-18
Effective immediately
TXSB2479PassRelating to procedures regarding certain persons who are or may be persons with a mental illness or intellectual disability.
[Detail][Text][Discuss]
2023-06-18
Effective on 9/1/23
TXSB773PassRelating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
[Detail][Text][Discuss]
2023-06-18
Effective immediately
TXSB867PassRelating to the recipients of opioid antagonists under the opioid antagonist program.
[Detail][Text][Discuss]
2023-06-17
Effective immediately
TXSB1179PassRelating to sexually violent predators and the prosecution of certain offenses involving prohibited items at correctional or civil commitment facilities; creating a criminal offense.
[Detail][Text][Discuss]
2023-06-02
Effective on 9/1/23
TXSB622PassRelating to the disclosure of certain prescription drug information by a health benefit plan.
[Detail][Text][Discuss]
2023-05-29
Effective on 9/1/23
TXSB2173PassRelating to a pilot program for the safe disposal of prescription drugs, including controlled substance prescription drugs.
[Detail][Text][Discuss]
2023-05-29
Effective on 9/1/23
TXSB241PassRelating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.
[Detail][Text][Discuss]
2023-05-27
Effective on . . . . . . . . . . . . . . . September 1, 2024
TXSB294PassRelating to the use of epinephrine auto-injectors and medication designated for treatment of respiratory distress on public and private school campuses.
[Detail][Text][Discuss]
2023-05-24
Effective immediately
TXSB2527Engross

Sine Die
Relating to the regulation of telemedicine medical services, teledentistry services, and telehealth services; providing a civil penalty.
[Detail][Text][Discuss]
2023-05-18
To House Public Health Committee
TXSB2212Engross

Sine Die
Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.
[Detail][Text][Discuss]
2023-05-06
To House Public Health Committee
TXSB301Engross

Sine Die
Relating to prescribing, administering, or dispensing ivermectin or hydroxychloroquine sulfate.
[Detail][Text][Discuss]
2023-04-28
To House Public Health Committee
TXSB1113Intro

Sine Die
Relating to prescription drug formularies applicable to the Medicaid managed care program.
[Detail][Text][Discuss]
2023-04-26
To Senate Health & Human Services Committee
TXSB1150Intro

Sine Die
Relating to prior authorization for prescription drug benefits related to the treatment of chronic and autoimmune diseases.
[Detail][Text][Discuss]
2023-04-26
To Senate Health & Human Services Committee
TXSB1619Intro

Sine Die
Relating to the determination of prescription drug reimbursement amounts under the Medicaid vendor drug program.
[Detail][Text][Discuss]
2023-04-26
To Senate Health & Human Services Committee
TXSB1138Intro

Sine Die
Relating to health benefit plan coverage of clinician-administered drugs.
[Detail][Text][Discuss]
2023-04-19
To Senate Health & Human Services Committee
TXSB2402Intro

Sine Die
Relating to the creation, management, and administration of the Texas Pharmaceutical Initiative.
[Detail][Text][Discuss]
2023-04-19
To Senate Health & Human Services Committee
TXSB426Engross

Sine Die
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
[Detail][Text][Discuss]
2023-04-17
To House Public Health Committee
TXSB2436Intro

Sine Die
Relating to covered benefits under the child health plan.
[Detail][Text][Discuss]
2023-03-23
To Senate Health & Human Services Committee
TXSB2455Intro

Sine Die
Relating to the medical use of low-THC cannabis by patients with certain medical conditions.
[Detail][Text][Discuss]
2023-03-23
To Senate Health & Human Services Committee
TXSB2448Intro

Sine Die
Relating to the use of funds appropriated by the Department of State Health Services to deliver low-dose, at-home racemic ketamine via telehealth to improve healthcare access and mental health outcomes across rural and high-risk populations.
[Detail][Text][Discuss]
2023-03-23
To Senate Health & Human Services Committee
TXSB2535Intro

Sine Die
Relating to the use of prescription glucagon medication on public and private school campuses.
[Detail][Text][Discuss]
2023-03-23
To Senate Education Committee
TXSB2201Intro

Sine Die
Relating to certain prescription drug benefits under the Medicaid managed care program.
[Detail][Text][Discuss]
2023-03-22
To Senate Health & Human Services Committee
TXSB1700Intro

Sine Die
Relating to the licensing and authority of advanced practice registered nurses.
[Detail][Text][Discuss]
2023-03-21
To Senate Health & Human Services Committee
TXSB1959Intro

Sine Die
Relating to the authority of a physician to supervise or delegate the prescribing or ordering of a drug or device to a physician assistant or advanced practice registered nurse.
[Detail][Text][Discuss]
2023-03-21
To Senate Health & Human Services Committee
TXSB1440Intro

Sine Die
Relating to the processing of certain credit card transactions; creating a criminal offense.
[Detail][Text][Discuss]
2023-03-16
To Senate State Affairs Committee
TXSB1580Intro

Sine Die
Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.
[Detail][Text][Discuss]
2023-03-16
To Senate Health & Human Services Committee
TXSB1576Intro

Sine Die
Relating to the effect of certain reductions in a health benefit plan enrollee's out-of-pocket expenses for certain prescription drugs on enrollee cost-sharing requirements.
[Detail][Text][Discuss]
2023-03-16
To Senate Health & Human Services Committee
TXSB1221Intro

Sine Die
Relating to modification of certain prescription drug benefits and coverage offered by certain health benefit plans.
[Detail][Text][Discuss]
2023-03-13
To Senate Health & Human Services Committee
TXSB1134Intro

Sine Die
Relating to certain information on the Texas Board of Nursing's Internet website regarding prescriptive authority agreements.
[Detail][Text][Discuss]
2023-03-09
To Senate Health & Human Services Committee
TXSB1198Intro

Sine Die
Relating to the statute of limitations on a health care liability claim involving certain gender modification drugs provided to and procedures performed on a minor.
[Detail][Text][Discuss]
2023-03-09
To Senate State Affairs Committee
TXSB954Intro

Sine Die
Relating to a statewide standing order prescribing opioid antagonists.
[Detail][Text][Discuss]
2023-03-03
To Senate Health & Human Services Committee
TXSB452Intro

Sine Die
Relating to step therapy protocols required by health benefit plans for coverage of prescription drugs for serious mental illnesses.
[Detail][Text][Discuss]
2023-02-17
To Senate Health & Human Services Committee
TXSB534Intro

Sine Die
Relating to the administration of certain drugs by a midwife.
[Detail][Text][Discuss]
2023-02-17
To Senate Health & Human Services Committee
TXSB634Intro

Sine Die
Relating to prior authorization for prescription drug benefits related to the treatment of chronic and autoimmune diseases.
[Detail][Text][Discuss]
2023-02-17
To Senate Health & Human Services Committee
TXSB78Intro

Sine Die
Relating to the provision of an abortion-inducing drug.
[Detail][Text][Discuss]
2023-02-15
To Senate State Affairs Committee
TXSB160Intro

Sine Die
Relating to the furnishing by pharmacists and dispensing by physicians of certain medications.
[Detail][Text][Discuss]
2023-02-15
To Senate Health & Human Services Committee
TXSB407Intro

Sine Die
Relating to covered benefits under the child health plan.
[Detail][Text][Discuss]
2023-02-15
To Senate Health & Human Services Committee
Syndicate content
feedback